Venous occlusion and Vitreous floaters

Summary:

Vitreous floaters is found among people with Venous occlusion, especially for people who are female, 50-59 old.

The study analyzes which people have Vitreous floaters with Venous occlusion. It is created by eHealthMe based on reports of 20 people who have Venous occlusion from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Venous occlusion?

Venous occlusion (the blocking of venous return) is found to be associated with 341 drugs and 432 conditions by eHealthMe. Check the latest studies of Venous occlusion.

What is Vitreous floaters?

Vitreous floaters (spots before the eyes) is found to be associated with 835 drugs and 838 conditions by eHealthMe. Check the latest studies of Vitreous floaters.

On Jul, 12, 2026

20 people who have Venous Occlusion and Vitreous Floaters are studied.

Would you have Vitreous floaters when you have Venous occlusion?

Gender of people who have Venous Occlusion and experienced Vitreous Floaters *:

female: 70 %
male: 30 %

Age of people who have Venous Occlusion and experienced Vitreous Floaters *:

Common co-existing conditions for these people *:

Normal Tension Glaucoma (a unique condition in which optic nerve damage and vision loss have occurred despite a normal pressure inside the eye): 9 people, 45.00%
Retinal Oedema (swelling of retina): 8 people, 40.00%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 7 people, 35.00%
Retinopathy (acute damage to the retina of the eye): 1 person, 5.00%
Metastases To Lung (cancer spreads to lung): 1 person, 5.00%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 5.00%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 1 person, 5.00%
Indigestion: 1 person, 5.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.00%
High Blood Pressure: 1 person, 5.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Vitreous Detachment (a condition of the eye in which the vitreous humour separates from the retina): 13 people, 65.00%
Eye Pain: 12 people, 60.00%
Eye Irritation: 11 people, 55.00%
Vitreous Opacities (vitreous opacities generally develop as aging changes within the eye): 9 people, 45.00%
Vision Blurred: 9 people, 45.00%
Scotoma (an area of diminished vision within the visual field): 9 people, 45.00%
Cuts And Puncture Wounds: 8 people, 40.00%
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest): 5 people, 25.00%
Visual Acuity Reduced (reduced clearness of vision): 4 people, 20.00%
Retinal Haemorrhage (bleeding from retina): 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Vitreous floaters?

- Check whether Vitreous floaters is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Venous occlusion (2,562 reports)
Vitreous floaters (10,893 reports)

All the drugs that are associated with Vitreous floaters:

Vitreous floaters (835 drugs)

All the conditions that are associated with Vitreous floaters:

Vitreous floaters (838 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Vitreous floaters and Venous occlusion, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.